Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 13, 2018 - Issue
Submit an article Journal homepage
54
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Effect of background long-acting beta2-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD

Edward M Kerwin1 Clinical Research Institute of Southern Oregon, Inc., Medford, OR, USA, [email protected]Correspondence[email protected]
,
Robert Tosiello2 Sunovion Pharmaceuticals Inc., Marlborough, MA, USA
,
Barry Price2 Sunovion Pharmaceuticals Inc., Marlborough, MA, USA
,
Shahin Sanjar2 Sunovion Pharmaceuticals Inc., Marlborough, MA, USA
&
Thomas Goodin2 Sunovion Pharmaceuticals Inc., Marlborough, MA, USA
Pages 2917-2929 | Published online: 19 Sep 2018

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.